Finding the Best Path Forward: FDA’s Norman Birenbaum Talks Hemp-Derived Product Regulation

After much speculation about how the U.S. Food and Drug Administration (FDA) might handle the regulation of CBD and other hemp-derived products, the agency announced last week that it does not intend to pursue rulemaking that allows the use of CBD in dietary supplements, conventional foods or animal products. Instead, agency officials indicated that Congress must establish a new regulatory framework for these products due to the unique safety issues associated with them.